Skip to content

Clinical trials

Phase 2 Sarcoma trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Sarcoma Phase: Phase 2 Country / region: United Kingdom Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20022
20031
20041
20051
20061
20071
20082
20104
20112
20152
20161
20171
20181
20192
20201
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Terminated5
Active, not recruiting3
Unknown status3
Not yet recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC5
Hoffmann-La Roche3
The Netherlands Cancer Institute2
AGC Biologics S.p.A.1
AstraZeneca1
Bristol-Myers Squibb1
Cambridge University Hospitals NHS Foundation Trust1
Centre Leon Berard1
Children's Cancer and Leukaemia Group1
Epizyme, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Sarcoma27
Sarcoma, Synovial5
Fibrosarcoma3
Histiocytoma, Malignant Fibrous3
Neoplasms3
Neuroectodermal Tumors, Primitive, Peripheral3
Ovarian Neoplasms3
Breast Neoplasms2
Carcinoma, Non-Small-Cell Lung2
Carcinoma, Renal Cell2

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.